---

• Pine Brook, NJ


• Contact:
  Ron Eastman
  
• Formerly Known As: E-Site Therapeutics

Related News

• Elusys Therapeutics’ Anthrax Drug Gains FDA Approval in Adults and Children
• Elusys Therapeutics Receives First Delivery Order from US Government for Anthim
• Elusys Awarded Additional $16 Million To Complete Development of Lyophilized Form of Anthim
• Elusys Therapeutics Presents Efficacy Results and Other Key Findings on ETI-204 Anthrax Anti-Toxin